The home of the Audio Journal of Oncology

Live Report from ASH:
Interleukin-2 For Acute Myeloid Leukemia In First Remission?

AudioMedica News
AudioMedica News
Live Report from ASH:
Interleukin-2 For Acute Myeloid Leukemia In First Remission?
Live Report from ASH:<br />Interleukin-2 For Acute Myeloid Leukemia In First Remission?
/
Jonathan Kolitz
Jonathan Kolitz

JONATHAN KOLITZ, Monter Cancer Center, Lake Success, NY
GEORGE CANELLOS, Dana-Farber Cancer Institute

For patients with acute myeloid leukemia in first remission, new data suggests that there may be a benefit from interleukin-2. Derek Thorne got the interim results of this phase III trial from Jonathan Kolitz of Monter Cancer Center, Lake Success, NY, while George Canellos of the Dana-Farber Cancer Institute provided comment.

Live Report from ASH:<br />Interleukin-2 For Acute Myeloid Leukemia In First Remission?
[audio:https://www.audiomedica.com/podcasting/oncology/071209_jonathan_kolitz.mp3]

Further reading

Sign up for AudioMedica.com news

* = required field
Speciality